Evidence map›Paper›PMID 41992957›Full record

ArticleMolecular medicine reports2026

Elevated IgG levels induce an M2‑to‑M1 phenotypic shift in mucosal macrophages and restrict the growth of invasive sphenoid sinus pituitary adenomas.

Xingbo Li, Zhuowei Lei, Sihan Li, Linpeng Xu, Quanji Wang, Qian Jiang, Zihan Wang, Huaqiu Zhang, Yimin Huang, Ting Lei

Abstract read
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xingbo LiSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Zhuowei LeiSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Sihan LiSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Linpeng XuSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Quanji WangSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Qian JiangSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Zihan WangSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Huaqiu ZhangSino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Yimin Huang *Sino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Ting Lei *Sino‑German Neuro‑Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although invasive pituitary adenomas (PAs) commonly invade the sellar floor and violate the dura mater, complete penetration of the sphenoid sinus mucosa is uncommon, and thus, mapping of the tumor‑mucosa immune landscape is warranted. In the present study, clinical PA specimens were analyzed via H&E staining, Masson's trichrome staining and immunohistochemistry. Spatial immune architecture and activation states were mapped by multiplex immunofluorescence staining. Two models, air‑liquid interface culture of mucosal tissue explants and co‑culture of dissociated mucosal cells with primary PA cells, were used to test mucosa‑derived inhibition. Cytokines were quantified using ELISAs. Tumor growth inhibition and cell cycle changes were assessed by flow cytometry. Intracellular signaling was examined by western blotting. Macrophage phagocytosis of pHrodo™‑labeled tumor cells was quantified. The sphenoid sinus mucosa retained structural integrity. Both co‑culture systems reduced proliferation (lower Ki‑67 labeling) and increased cell death (higher annexin V/PI positivity) in primary PA cells, with effects more pronounced in co‑cultures with enzymatically digested mucosa than with intact mucosal tissue fragments. Macrophages were predominant at the invasive fronts and repolarized from immunoregulatory (M2) to pro‑inflammatory (M1) phenotypes. Mucosal macrophages expressed significantly more IFN‑γ than their intratumoral counterparts. High IFN‑γ levels were associated with lower Ki‑67 levels, and exogenous IFN‑γ suppressed PA cell proliferation and migration via S‑phase arrest and Janus kinase‑STAT1 activation. Mucosal B cell‑derived IgG levels were higher than IgA levels and were associated with M1‑like macrophages rather than M2‑like macrophages. IgG treatment increased M2 macrophage pro‑inflammatory cytokine levels, particularly IL‑6 levels. IL‑6 induced G1‑phase arrest. Combined IL‑6 and IFN‑γ treatment increased STAT1 phosphorylation compared with that observed after IFN‑γ treatment alone, without increasing STAT3 activation beyond the activation induced by IL‑6 alone, thereby reducing PA cell proliferation and migration. In co‑culture experiments, anti‑CD47 monoclonal antibody enhanced macrophage‑mediated antibody‑dependent cellular phagocytosis and was associated with reduced tumor cell proliferation. In conclusion, the sphenoid sinus mucosa establishes an immune barrier centered on M1‑polarized macrophages and IgG‑high B cells. This network generates an IFN‑γ/IL‑6 gradient that restricts local PA progression, and highlights macrophage/B cell‑directed and CD47‑targeted approaches as potential adjuncts to surgery.

Indexed as

AdenomaImmunoglobulin GMacrophagesPituitary NeoplasmsAdultAgedCell ProliferationCoculture TechniquesCytokinesFemaleHumansMaleMiddle AgedPhagocytosisPhenotypeSTAT1 Transcription FactorCytokinesImmunoglobulin GSTAT1 Transcription Factoranti‑CD47 monoclonal antibodyIgGmucosal macrophagespituitary adenomas

Identifiers

PMID41992957
PMCPMC13107097

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.